AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 35 filers reported holding AVEO PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.92 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $4,124 | -99.8% | 275,892 | +2.8% | 0.00% | – |
| Q3 2022 | $2,208,000 | +18.6% | 268,314 | -5.5% | 0.00% | – |
| Q2 2022 | $1,862,000 | +24.1% | 283,969 | +5.7% | 0.00% | – |
| Q1 2022 | $1,501,000 | +23.5% | 268,684 | +3.7% | 0.00% | – |
| Q4 2021 | $1,215,000 | -21.3% | 259,065 | +3.6% | 0.00% | – |
| Q3 2021 | $1,544,000 | -4.6% | 249,969 | +1.8% | 0.00% | – |
| Q2 2021 | $1,618,000 | -44.4% | 245,645 | -38.3% | 0.00% | – |
| Q1 2021 | $2,912,000 | +57.4% | 397,937 | +24.1% | 0.00% | – |
| Q4 2020 | $1,850,000 | +12.2% | 320,675 | +15.4% | 0.00% | – |
| Q3 2020 | $1,649,000 | +64.2% | 277,771 | +42.4% | 0.00% | – |
| Q2 2020 | $1,004,000 | +184.4% | 195,026 | +99.8% | 0.00% | – |
| Q1 2020 | $353,000 | – | 97,599 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 1,986,176 | $12,275,000 | 2.58% |
| Worth Venture Partners, LLC | 454,364 | $2,808,000 | 1.26% |
| Opaleye Management Inc. | 455,600 | $2,816,000 | 0.53% |
| J. Goldman & Co LP | 1,663,229 | $10,279,000 | 0.52% |
| X-Square Capital, LLC | 92,283 | $570,000 | 0.30% |
| NEA Management Company, LLC | 3,952,958 | $24,429,000 | 0.29% |
| Birchview Capital, LP | 40,000 | $247,000 | 0.17% |
| PERSONAL CFO SOLUTIONS, LLC | 23,000 | $142,000 | 0.03% |
| PURA VIDA INVESTMENTS, LLC | 147,574 | $912,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 35,232 | $218,000 | 0.02% |